We successfully used RNAi technology to construct a recombinant MBD1-siRNA plasmid that stably knocked-down MBD1 gene expression in the BxPC-3 human pancreatic cancer cell line. The gene discussed is MBD1; the disease is familial pancreatic carcinoma.